Nuvation Bio
D

NUVB

4.56500
USD
-0.04
(-0.87%)
Market Open
Last updated: · Delayed 15 min
Volume
50,916
EPS
-0
Div Yield
-
P/E
-10
Market Cap
1,602,877,559
Overview
Related Instruments
CMCSA
CMCSA
D
Comcast Corp
22.020
-0.645(-2.84%)
FOXA
FOXA
D
Fox Corp
65.530
-1.060(-1.59%)
IHRT
D
iHeartMedia
1.81000
-0.05500(-2.95%)
LUMN
D
Lumen Technologies
4.47500
-0.09000(-1.97%)
NFLX
NFLX
D
Netflix
63.090
-2.770(-4.21%)
SIRI
D
Sirius XM Holdings
27.290
-0.330(-1.19%)
T
T
D
AT&T
20.995
0.060(0.29%)
More

Title: Nuvation Bio

Sector: Healthcare
Industry: Biotechnology
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.